Literature DB >> 25466178

Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR.

Mirco Zeiger1, Sebastian Stark1, Elisabeth Kalden1, Bettina Ackermann1, Jan Ferner1, Ute Scheffer1, Fatemeh Shoja-Bazargani1, Veysel Erdel1, Harald Schwalbe1, Michael W Göbel2.   

Abstract

Basic molecular building blocks such as benzene rings, amidines, guanidines, and amino groups have been combined in a systematic way to generate ligand candidates for HIV-1 TAR RNA. Ranking of the resulting compounds was achieved in a fluorimetric Tat-TAR competition assay. Although simple molecules such as phenylguanidine are inactive, few iteration steps led to a set of ligands with IC50 values ranging from 40 to 150 μM. 1,7-Diaminoisoquinoline 17 and 2,4,6-triaminoquinazoline 22 have been further characterized by NMR titrations with TAR RNA. Compound 22 is bound to TAR at two high affinity sites and shows slow exchange between the free ligand and the RNA complex. These results encourage investigations of dimeric ligands built from two copies of compound 22 or related heterocycles.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amidine; Guanidine; Ligand; NMR; RNA

Mesh:

Substances:

Year:  2014        PMID: 25466178     DOI: 10.1016/j.bmcl.2014.11.004

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  SHAPE-enabled fragment-based ligand discovery for RNA.

Authors:  Meredith J Zeller; Oleg Favorov; Kelin Li; Ashok Nuthanakanti; Dina Hussein; Auréliane Michaud; Daniel A Lafontaine; Steven Busan; Alexander Serganov; Jeffrey Aubé; Kevin M Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-13       Impact factor: 12.779

2.  Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR.

Authors:  Neeraj N Patwardhan; Laura R Ganser; Gary J Kapral; Christopher S Eubanks; Janghyun Lee; Bharathwaj Sathyamoorthy; Hashim M Al-Hashimi; Amanda E Hargrove
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

3.  Subsite Ligand Recognition and Cooperativity in the TPP Riboswitch: Implications for Fragment-Linking in RNA Ligand Discovery.

Authors:  Meredith J Zeller; Ashok Nuthanakanti; Kelin Li; Jeffrey Aubé; Alexander Serganov; Kevin M Weeks
Journal:  ACS Chem Biol       Date:  2022-01-21       Impact factor: 5.100

Review 4.  The Emerging Role of RNA as a Therapeutic Target for Small Molecules.

Authors:  Colleen M Connelly; Michelle H Moon; John S Schneekloth
Journal:  Cell Chem Biol       Date:  2016-09-01       Impact factor: 8.116

5.  Iron(II) supramolecular helicates interfere with the HIV-1 Tat-TAR RNA interaction critical for viral replication.

Authors:  Jaroslav Malina; Michael J Hannon; Viktor Brabec
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

Review 6.  Small molecules targeting viral RNA.

Authors:  Thomas Hermann
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-06-16       Impact factor: 9.957

Review 7.  Unveiling the druggable RNA targets and small molecule therapeutics.

Authors:  Joanna Sztuba-Solinska; Gabriela Chavez-Calvillo; Sabrina Elizabeth Cline
Journal:  Bioorg Med Chem       Date:  2019-03-30       Impact factor: 3.641

8.  An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.

Authors:  Matthew D Shortridge; Paul T Wille; Alisha N Jones; Amy Davidson; Jasmina Bogdanovic; Eric Arts; Jonathan Karn; John A Robinson; Gabriele Varani
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

9.  19 F NMR-Based Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and Protein Counter-Screens.

Authors:  Oliver Binas; Vanessa de Jesus; Tom Landgraf; Albrecht Eduard Völklein; Jason Martins; Daniel Hymon; Jasleen Kaur Bains; Hannes Berg; Thomas Biedenbänder; Boris Fürtig; Santosh Lakshmi Gande; Anna Niesteruk; Andreas Oxenfarth; Nusrat Shahin Qureshi; Tatjana Schamber; Robbin Schnieders; Alix Tröster; Anna Wacker; Julia Wirmer-Bartoschek; Maria Alexandra Wirtz Martin; Elke Stirnal; Kamal Azzaoui; Christian Richter; Sridhar Sreeramulu; Marcel Jules José Blommers; Harald Schwalbe
Journal:  Chembiochem       Date:  2020-09-25       Impact factor: 3.461

10.  Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.

Authors:  Megan L Kelly; Chia-Chieh Chu; Honglue Shi; Laura R Ganser; Hal P Bogerd; Kelly Huynh; Yuze Hou; Bryan R Cullen; Hashim M Al-Hashimi
Journal:  RNA       Date:  2020-10-07       Impact factor: 5.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.